CEACAM1 protects the liver from MASLD and MASH by maintaining normal hepatic insulin clearance, reducing excessive FASN-induced hepatic fat accumulation and inflammation. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.